Answer
In 12-month clinical data for Combigan, the most commonly reported adverse effects were conjunctival hyperaemia (approximately 15%) and burning sensation in the eye (approximately 11%), with most cases mild.
Sources for this answer
- CombiganAbbVie Ltd · emc · SmPC §4.8 Undesirable effects · Version 14Document updated
Sources checked